ICD-coded information on sites of metastasis in oncology real-world data is specific but not sensitive Published May 2018 Citation Parrinello, C.M., Seidl-Rathkopf, K.N., Bennette, C, Bourla, A.B., Nussbaum, N.C., Carson, K.R., Abernethy, A.P. . ISPOR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/Sites-of-Mets-Structured-vs-Unstructured-ISPOR-2018-Poster_Vertical_Final_MM.pdf Authors: Sources:ISPOR Annual Meeting Share Posted inPublications More publicationsESMO OpenSeptember 2025Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practiceRugo H, Layman R, Lynce F, et al.Publication summaryPublicationsComparative effectivenessMetastatic breast cancerBreast cancerWorld Conference on Lung CancerAugust 2025Disease burden and rwPFS as a surrogate endpoint for rwOS in NTRK+ NSCLC and other advanced/metastatic solid tumorFlores Avile C, Su I-H, Huang P-C, Cho-Phan C, Camidge R, Yuan Y.Publication summaryPublicationsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer